Gelteq Ltd
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
other
SEC Category
Non-accelerated filerEmerging growth company
State of Incorporation
Australia
Country
Australia
Business Address
LEVEL 4, SOUTH MELBOURNE VIC, ,
Mailing Address
LEVEL 4, SOUTH MELBOURNE VIC, ,
Phone
61390873990
Fiscal Year End
0630
EIN
000000000
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 6-K Foreign company current report | March 24, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 3 Initial insider ownership report | March 18, 2026 | View on SEC |
| 6-K Foreign company current report | December 9, 2025 | View on SEC |
| 20-F Foreign company annual report | November 17, 2025 | View on SEC |
| F-1/A Foreign IPO registration amendment | July 25, 2025 | View on SEC |
| F-1 Foreign company IPO registration | July 1, 2025 | View on SEC |
| 6-K Foreign company current report | June 30, 2025 | View on SEC |
Annual Reports
20-F
November 17, 2025
- Launched EverPatch glucose-monitoring patch, sold out in 3 months
- Expanded into Europe, 20% of revenue from Germany and France
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.